Ignite Creation Date:
2025-12-25 @ 2:49 AM
Ignite Modification Date:
2026-03-05 @ 3:34 PM
Study NCT ID:
NCT00524433
Status:
COMPLETED
Last Update Posted:
2018-07-10
First Post:
2007-08-31
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Tezosentan in the Treatment of Acute Heart Failure
Sponsor:
Idorsia Pharmaceuticals Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2003-04
Start Date Type:
None
Primary Completion Date:
2005-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2005-01
Completion Date Type:
ACTUAL
First Submit Date:
2007-08-31
First Submit QC Date:
None
Study First Post Date:
2007-09-03
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-07-06
Last Update Post Date:
2018-07-10
Last Update Post Date Type:
ACTUAL